+49 30 327787-0
The Legal 500 EMEA recommends D+B in three practice areas: healthcare law, regulatory advisory, and healthcare.
The Legal 500, one of the leading international lawyer directories, has published its 2026 Europe, Middle East & Africa edition. In this ranking, D+B is recommended in three practice areas: healthcare law, regulatory advice, and healthcare.
The Legal 500 EMEA recommends D+B in three practice areas: healthcare law, regulatory advisory, and healthcare.
The Legal 500, one of the leading international lawyer directories, has published its 2026 Europe, Middle East & Africa edition. In this ranking, D+B is recommended in three practice areas: healthcare law, regulatory advice, and healthcare.
Schwerpunkte der Anpassung des Leistungsgruppensystems durch das Krankenhausreformanpassungsgesetz – KHAG
Der Deutsche Bundestag hat in seiner 63. Sitzung am 06.03. 2026 das Krankenhausreformanpassungsgesetz (KHAG) beschlossen. Ziel des Gesetzes ist es, die Umsetzung der Krankenhausreform (KHVVG) praxistauglicher zu gestalten und gleichzeitig eine qualitativ hochwertige, wohnortnahe Versorgung dauerhaft zu sichern.
AI-based Medical Devices - Lexology
In the newly published article on Lexology, our lawyers Dr. Ulrich Grau, Dr. Tobias Volkwein and Dr. David Shaverdov discuss AI-based medical devices and the regulatory challenges they pose.
AI-based Medical Devices - Lexology
In the newly published article on Lexology, our lawyers Dr. Ulrich Grau, Dr. Tobias Volkwein and Dr. David Shaverdov discuss AI-based medical devices and the regulatory challenges they pose.
CHAMBERS GERMANY 2026 AWARDS D+B
In 2026, Chambers Germany Guide has once again recognised D+B, awarding it the second-highest category in the Healthcare sector and the fourth-highest in Life Sciences. According to Chambers Germany, the team is known as “…an outstanding healthcare boutique boasting a renowned reputation for regulatory affairs, with additional strength in life sciences mandates. It offers notable expertise in market access, patient data protection issues and healthcare transactions, and often acts for hospitals, doctors, pharmacists and pharmaceutical companies.
CHAMBERS GERMANY 2026 AWARDS D+B
In 2026, Chambers Germany Guide has once again recognised D+B, awarding it the second-highest category in the Healthcare sector and the fourth-highest in Life Sciences. According to Chambers Germany, the team is known as “…an outstanding healthcare boutique boasting a renowned reputation for regulatory affairs, with additional strength in life sciences mandates. It offers notable expertise in market access, patient data protection issues and healthcare transactions, and often acts for hospitals, doctors, pharmacists and pharmaceutical companies.
The Legal 500 empfiehlt D+B in drei Praxisbereichen: Medizinrecht, regulatorische Beratung sowie Gesundheit
The Legal 500, eines der führenden internationalen Anwaltsverzeichnisse, hat die Deutschland-Ausgabe für das Jahr 2026 veröffentlicht. Darin wird D+B in drei Praxisbereichen empfohlen: Medizinrecht, regulatorische Beratung sowie Gesundheit.
Die Spitzenposition Tier 1 im Bereich regulatorische Beratung wird seit 2022 durchgehend von D+B belegt. Seit 2023 hält D+B diese Position zusätzlich im Bereich Medizinrecht. Weiterhin belegt D+B im Bereich Gesundheit Tier 2.
D+B goes Red
Der National Wear Red Day® inspiriert – doch in Deutschland braucht das Thema Herzgesundheit von Frauen mehr Aufmerksamkeit denn je. Herz-Kreislauf-Erkrankungen sind weiterhin die häufigste Todesursache bei Frauen, und das Risiko wird noch immer unterschätzt. Frauenherzen schlagen anders – in der Symptomatik, in der Diagnostik und in der Therapie.
D+B named ‘TOP Law Firm 2026’ in the current WirtschaftsWoche listing
We are delighted that D+B has been named ‘TOP Law Firm 2026’ in the current WirtschaftsWoche listing in the legal field of ‘Medical Law (Service Providers)’.
WHEN IT MATTERS.